FABPulous

company

About

FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.

  • 1 - 10

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.

FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, Health Innovations, Limburg Ventures and NV Industriebank LIOF.

The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€1.80M
FABPulous has raised a total of €1.80M in funding over 2 rounds. Their latest funding was raised on Feb 4, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 4, 2015 Series B €1.80M 1 Detail
Jan 11, 2010 Series A 1 Limburg Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
FABPulous is funded by 1 investors. Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Limburg Ventures Series B